Shattuck is a biotechnology company developing a potentially first-in-class antibody for the treatment of Inflammatory Bowel Disease (IBD) and other inflammatory autoimmune diseases. Shattuck's expertise in protein engineering and commitment to pursuing the development of novel therapeutics targeting TNF receptors come together in its lead program, SL-325, a first-in-class DR3 antagonist antibody designed to achieve complete and more durable blockade of the clinically validated TL1A/DR3 pathway. Shattuck has offices in both Austin, Texas, and Durham, North Carolina.
Company Details
- Employees
- 56
- Founded
- -
- Address
- Austin, Texas 78703, Us
- Phone
- (917) 892-9996
- co****@****abs.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- shattucklabs.com
- Keywords
- Chapel Hill.
- HQ
- Austin, Texas
Shattuck Labs Questions
Shattuck Labs's helpline number is (917) 892-9996
Shattuck Labs's website is shattucklabs.com
Shattuck Labs's LinkedIn profile is https://www.linkedin.com/company/shattuck-labs
Shattuck Labs has
56 employees.
View email and phone details for 56
employees at Shattuck Labs.
Shattuck Labs's industry is
Biotechnology Research
Shattuck Labs's top competitors are
Oncternal Therapeutics,
Aeglea Biotherapeutics,
Lumos Pharma,
Pathfinder Oncology,
Immunitybio, Inc.,
Sage Therapeutics,
Athira Pharma,
Turnstone Biologics,
Bluebird Bio,
Kbi Biopharma.
Shattuck Labs's support email address is contact@shattucklabs.com
Shattuck Labs's categories are Biotechnology Research
Shattuck Labs's founding year is 2016
